Consistent with the retrospective study which suggested the event-free outcomes for patients with lower eGFR levels was significantly shortened ( 28 ), our results displayed significant difference regarding composite endpoint among different eGFR groups, whereas we saw a significant trend that patients with impaired kidney function in the dabigatran anticoagulant population might experience shorter event-free outcomes.
← all excerpts
Impact of Renal Function on Effectiveness and Safety Associated With Low Dose Dabigatran in Non-valve Atrial Fibrillation Patients After Catheter Ablation.
1
—
—